XML 27 R4.htm IDEA: XBRL DOCUMENT v3.21.1
CONSOLIDATED STATEMENT OF OPERATIONS - USD ($)
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Income Statement [Abstract]    
Sales, net [1] $ 25,027,637 $ 6,347,160
Cost of Sales [1] 9,985,046 2,433,243
Gross Profit [1] 15,042,591 3,913,917
Operating Expenses:    
Professional Fees [1] 681,377 363,789
Depreciation and Amortization [1] 719,760 716,165
Selling Expenses [1] 1,247,444 1,654,564
Research and Development [1] 455,046 340,582
Equity Compensation Expense (Note 11) [1] 3,130,986 114,222
Consulting fees [1] 327,232 126,693
General and Administrative [1] 3,971,956 2,681,146
Total Operating Expenses [1] 10,533,802 5,997,161
Income (Loss) from Operations [1] 4,508,789 (2,083,244)
Other Income (Expense):    
Amortization of Debt Discounts [1] 0 (17,534)
Interest Income [1] 2,915 3,045
Interest expense [1] (43,538) (200,000)
Total Other Income (Expense) [1] (40,623) (214,489)
Income (Loss) Before Income Taxes [1] 4,468,166 (2,297,733)
Provision for Income Taxes (Note 17) [1] 77,000 0
Net Income (Loss) [1] $ 4,391,166 $ (2,297,733)
Net Income (Loss) Per Common Share:    
Basic [1] $ 0.27 $ (0.15)
Diluted [1] $ 0.23 $ (0.15)
Basic Weighted Average Common Shares Outstanding [1] 16,512,126 15,586,258
Diluted Weighted Average Common Shares Outstanding [1] 18,757,509 15,586,258
[1] Share amounts with respect to the common stock and Convertible Series A Preferred Stock have been retroactively restated to reflect the reverse split thereof, which was effected as of the close of business on September 10, 2020. Refer to Note 11 - Equity for further information.